Article Text

Download PDFPDF

Inhaled corticosteroids moderate lung function decline in adults with asthma
  1. P Ernst
  1. Correspondence to:
    Dr P Ernst
    Division of Clinical Epidemiology, Royal Victoria Hospital, Montreal, Quebec, Canada, H3A 1A1; pierre.ernst{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Further evidence of the benefit of long term inhaled corticosteroids in asthma

Inhaled corticosteroids are the mainstay of asthma treatment. They have earned this central place in our therapeutic armamentarium by their rapid alleviation of persistent asthma symptoms, improvement in lung function, prevention of exacerbations including those severe enough to require hospitalisation, and by preventing asthma deaths, even at low doses.1,2 They appear indicated as maintenance therapy for asthma patients who have more than occasional respiratory symptoms,3 and probably need to be used regularly to provide benefit.4 A recent study suggesting the contrary used a protocol of initial intense treatment with inhaled and oral corticosteroids which is not readily applicable clinically.5

Patients with asthma have a more rapid decline in lung function over time which results in significant irreversible airways obstruction in a substantial minority (estimates range from 23% to 33%).6–9 Such fixed airflow limitation in asthma appears to be a manifestation of airway remodelling.10 While corticosteroids have many actions which might be expected to limit such remodelling, there is no …

View Full Text

Linked Articles

  • Airwaves
    Wisia Wedzicha